S. Pollack

发表

Structural analysis of inositol monophosphatase complexes with substrates.

J. Springer, R. Bone, L. Frank, 1994, Biochemistry.

Semisynthetic Catalytic Antibodies

P. Schultz, S. Pollack, 1990 .

Design of catalytic antibodies.

P. Schultz, S. Pollack, G. Nakayama, 1989, Methods in enzymology.

Neurotrophic Factor Mimetics

S. Harper, S. Pollack, F. Hefti, 1999 .

Stereospecific Hydrolysis of Alkyl Esters by Antibodies

P. Schultz, S. Pollack, P. Hsiun, 1989 .

A semisynthetic catalytic antibody

P. Schultz, S. Pollack, 1989 .

Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.

S. Pollack, H. Lewis, 2005, Current opinion in investigational drugs.

Catalytic Site-Directed γ-Secretase Complex Inhibitors Do Not Discriminate Pharmacologically between Notch S3 and β-APP Cleavages

A. Nadin, S. Pollack, J. G. Neduvelil, 2003 .

The non‐peptidyl fungal metabolite L‐783,281 activates TRK neurotrophin receptors

J. Bilsland, L. Young, S. Harper, 2001, Journal of neurochemistry.

Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B

A. Barr, K. Fütterer, S. Pollack, 2019, bioRxiv.

Small molecule Trk receptor agonists and other neurotrophic factor mimetics.

S. Harper, S. Pollack, 2002, Current drug targets. CNS and neurological disorders.

Antibody catalysis by transition state stabilization.

P. Schultz, S. Pollack, P. Schultz, 1987, Cold Spring Harbor symposia on quantitative biology.

Sulphated compounds attenuate β-amyloid toxicity by inhibiting its association with cells

S. Pollack, C. Ragan, M. Shearman, 1995, Neuroreport.

Selective chemical catalysis by an antibody.

P G Schultz, P. Schultz, S. Pollack, 1986, Science.

Inositol monophosphatase — a putative target for Li+ in the treatment of bipolar disorder

S. Pollack, J. Atack, H. Broughton, 1995, Trends in Neurosciences.

The toxicity in vitro of beta-amyloid protein.

L. Iversen, R. Mortishire-Smith, S. Pollack, 1995, The Biochemical journal.

Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.

P. Lograsso, S. Pollack, P. Hunt, 2005, Archives of biochemistry and biophysics.

The staurosporine-like compound L-753,000 (NB-506) potentiates the neurotrophic effects of neurotrophin-3 by acting selectively at the TrkA receptor.

J. Bilsland, L. Young, S. Harper, 1999, Molecular pharmacology.

Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesis.

S. Pollack, S. Osborne, J. Atack, 1993, European journal of biochemistry.

Introduction of nucleophiles and spectroscopic probes into antibody combining sites.

G R Nakayama, P G Schultz, P. Schultz, 1988, Science.

Heparan sulfates are critical regulators of the inhibitory 1 megakaryocyte-platelet receptor G 6 b-B 2 3

A. Barr, K. Fütterer, S. Pollack, 2022 .

A comparative study of fragment screening methods on the p38α kinase: new methods, new insights

Doris Hafenbradl, Thomas Ahrens, Christopher Lock, 2011, J. Comput. Aided Mol. Des..

Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components

Piergiorgio Strata, J. Fawcett, P. Strata, 2006, The Journal of comparative neurology.

Proto-oncogenes andtheCardiovascular

S. Pollack, 2017 .

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells

S. Pollack, M. Shearman, S. Hawtin, 1995, Neuroscience Letters.

Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion

S. Pollack, M. Shearman, S. Hawtin, 1995, Neuroscience Letters.

Structural analysis of inositol monophosphatase complexes with substrates.

J. Springer, R. Bone, L. Frank, 1995, Biochemistry.

Cloning, overexpression and mechanistic studies of carboxyphosphonoenolpyruvate mutase from Streptomyces hygroscopicus.

J. Knowles, S. Pollack, D. Pompliano, 1992, European journal of biochemistry.

Structure and mechanism of inositol monophosphatase

S. Pollack, J. Atack, H. Broughton, 1995, FEBS letters.

Mechanism of inositol monophosphatase, the putative target of lithium therapy.

L. L. Iversen, S. Pollack, J. Atack, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.

A. Nadin, S. Pollack, J. G. Neduvelil, 2003, Biochemistry.

Asymmetric, biocatalytic labeled compound synthesis using transaminases

S. Pollack, I. Davies, M. Truppo, 2012 .

Trk Neurotrophin Receptor Activators.

S. Harper, S. Pollack, 2002, Drug news & perspectives.